161 related articles for article (PubMed ID: 31286201)
1. Synergistic application of pulmonary
Fraioli F; Lyasheva M; Porter JC; Bomanji J; Shortman RI; Endozo R; Wan S; Bertoletti L; Machado M; Ganeshan B; Win T; Groves AM
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2023-2031. PubMed ID: 31286201
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary
Win T; Screaton NJ; Porter JC; Ganeshan B; Maher TM; Fraioli F; Endozo R; Shortman RI; Hurrell L; Holman BF; Thielemans K; Rashidnasab A; Hutton BF; Lukey PT; Flynn A; Ell PJ; Groves AM
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):806-815. PubMed ID: 29335764
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CT.
Groves AM; Win T; Screaton NJ; Berovic M; Endozo R; Booth H; Kayani I; Menezes LJ; Dickson JC; Ell PJ
J Nucl Med; 2009 Apr; 50(4):538-45. PubMed ID: 19289428
[TBL] [Abstract][Full Text] [Related]
4. [
Justet A; Laurent-Bellue A; Thabut G; Dieudonné A; Debray MP; Borie R; Aubier M; Lebtahi R; Crestani B
Respir Res; 2017 Apr; 18(1):74. PubMed ID: 28449678
[TBL] [Abstract][Full Text] [Related]
5. The Value of
Yoon HY; Lee SH; Ha S; Ryu JS; Song JW
J Korean Med Sci; 2021 Oct; 36(41):e257. PubMed ID: 34697928
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET/CT in the prediction of pulmonary function improvement in nonspecific interstitial pneumonia. A Pilot Study.
Jacquelin V; Mekinian A; Brillet PY; Nunes H; Fain O; Valeyre D; Soussan M
Eur J Radiol; 2016 Dec; 85(12):2200-2205. PubMed ID: 27842667
[TBL] [Abstract][Full Text] [Related]
7. Can FDG-PET/CT imaging be used to predict decline in quality of life in interstitial lung disease? A prospective study of the relationship between FDG uptake and quality of life in a UK outpatient setting.
Jordon LH; Ganeshan B; Nadeem I; Hoy L; Mahdi N; Porter JC; Groves A; Win T
BMJ Open; 2024 May; 14(5):e081103. PubMed ID: 38816048
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. Combination of positron emission tomography/computed tomography and chest thin-layer high-resolution computed tomography for evaluation of pulmonary nodules: Correlation with imaging features, maximum standardized uptake value, and pathology.
Hou S; Lin X; Wang S; Shen Y; Meng Z; Jia Q; Tan J
Medicine (Baltimore); 2018 Aug; 97(31):e11640. PubMed ID: 30075545
[TBL] [Abstract][Full Text] [Related]
10. Is
Lee SH; Sung C; Lee HS; Yoon HY; Kim SJ; Oh JS; Song JW; Kim MY; Ryu JS
Ann Nucl Med; 2018 Aug; 32(7):492-498. PubMed ID: 29974372
[TBL] [Abstract][Full Text] [Related]
11. Areas of normal pulmonary parenchyma on HRCT exhibit increased FDG PET signal in IPF patients.
Win T; Thomas BA; Lambrou T; Hutton BF; Screaton NJ; Porter JC; Maher TM; Endozo R; Shortman RI; Afaq A; Lukey P; Ell PJ; Groves AM
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):337-42. PubMed ID: 23942907
[TBL] [Abstract][Full Text] [Related]
12.
Yoon HY; Lee SH; Ha S; Ryu JS; Song JW
BMC Pulm Med; 2021 Sep; 21(1):294. PubMed ID: 34530787
[TBL] [Abstract][Full Text] [Related]
13. 68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results.
Ambrosini V; Zompatori M; De Luca F; Antonia D; Allegri V; Nanni C; Malvi D; Tonveronachi E; Fasano L; Fabbri M; Fanti S
J Nucl Med; 2010 Dec; 51(12):1950-5. PubMed ID: 21078794
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Dual-Time-Point 18F-FDG PET for Idiopathic Pulmonary Fibrosis.
Umeda Y; Demura Y; Morikawa M; Anzai M; Kadowaki M; Ameshima S; Tsuchida T; Tsujikawa T; Kiyono Y; Okazawa H; Ishizaki T; Ishizuka T
J Nucl Med; 2015 Dec; 56(12):1869-75. PubMed ID: 26359263
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of standardized uptake value on preoperative ¹⁸F-FDG PET/CT in patients with ampullary adenocarcinoma.
Choi HJ; Kang CM; Jo K; Lee WJ; Lee JH; Ryu YH; Lee JD
Eur J Nucl Med Mol Imaging; 2015 May; 42(6):841-7. PubMed ID: 25216749
[TBL] [Abstract][Full Text] [Related]
17. Role of PET/CT in Management of Early Lung Adenocarcinoma.
Shao X; Niu R; Jiang Z; Shao X; Wang Y
AJR Am J Roentgenol; 2020 Feb; 214(2):437-445. PubMed ID: 31714848
[No Abstract] [Full Text] [Related]
18. The Diagnostic Value of FDG PET/CT and Thin-Slice High-Resolution Chest CT in Pulmonary Intravascular Metastasis.
Ji Y; Shao CC; Cui Y; Cui K; Shao GR; Zheng JS
AJR Am J Roentgenol; 2021 Mar; 216(3):769-775. PubMed ID: 33405948
[No Abstract] [Full Text] [Related]
19. Filtration-histogram based texture analysis and CALIPER based pattern analysis as quantitative CT techniques in idiopathic pulmonary fibrosis: head-to-head comparison.
AlDalilah Y; Ganeshan B; Endozo R; Bomanji J; Porter JC; Machado M; Bertoletti L; Lilburn D; Lyasheva M; Groves AM; Fraioli F
Br J Radiol; 2022 Jun; 95(1134):20210957. PubMed ID: 35191759
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT and HRCT: a combined tool for risk stratification in idiopathic inflammatory myopathy-associated interstitial lung disease.
Zhang Y; Chen Z; Long Y; Zhang B; He Q; Tang K; Zhang X
Clin Rheumatol; 2022 Oct; 41(10):3095-3105. PubMed ID: 35759126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
